Persones / Equip Humà

Angel Montero Carcaboso

Buscador de publicacions

Publicacions

  • Castillo H, Pascual-Pastó G, Pérez-Jaume S, Resa-Parés C, Vilà-Ubach M, Monterrubio C, Jimenez-Cabaco A, Baulenas-Farrés M, Muñoz-Aznar O, Salvador-Marcos N, Cuadrado-Vilanova M, Gene-Olaciregui N, Balaguer-Lluna L, Burgeño-Sandoval V, Vicario FJ, Manzanares-Quintela A, Castañeda-Heredia A, Santa-María López V, Cruz-Martínez O, Celis-Passini V, Morales-La Madrid A, Garraus-Oneca M, Gorostegui M, Vancells M, Carrasco-Torrents R, Krauel L, Torner-Rubies F, Suñol M, Lavarino C, Mora J and Carcaboso AM.

    Prognostic value of patient-derived xenograft engraftment in pediatric sarcomas

    JOURNAL OF PATHOLOGY CLINICAL RESEARCH . 7(4): 338-349. Nº de cites: 17

    [doi:10.1002/cjp2.210]

  • Vassileva V, Braga M, Barnes C, Przystal J, Ashek A, Allott L, Brickute D, Abrahams J, Suwan K, Carcaboso AM, Hajitou A and Aboagye EO.

    Effective Detection and Monitoring of Glioma Using [18F]FPIA PET Imaging

    Biomedicines . 9(7): 811. Nº de cites: 6

    [doi:10.3390/biomedicines9070811]

  • Ferretti R, Baldassarre A, Billy E, Carcaboso AM, Moore A, Carai A, Mastronuzzi A, Masotti A and Vinci M.

    Tumor cell invasion into Matrigel: optimized protocol for RNA extraction

    Biotechniques . : 327-335. Nº de cites: 2

    [doi:10.2144/btn-2021-0001]

  • Bailleul Q, Navarin P, Arcicasa M, Bal-Mahieu C, Carcaboso AM, Le Bourhis X, Furlan A, Meignan S and Leblond P.

    Evofosfamide Is Effective against Pediatric Aggressive Glioma Cell Lines in Hypoxic Conditions and Potentiates the Effect of Cytotoxic Chemotherapy and Ionizing Radiations

    Cancers . 13(8): 1804. Nº de cites: 6

    [doi:10.3390/cancers13081804]

  • Bukchin A, Sanchez-Navarro M, Carrera A, Resa-Parés C, Castillo H, Balaguer-Lluna L, Teixidó M, Gene-Olaciregui N, Giralt E, Carcaboso AM and Sosnik A.

    Amphiphilic Polymeric Nanoparticles Modified with a Protease-Resistant Peptide Shuttle for the Delivery of SN-38 in Diffuse Intrinsic Pontine Glioma

    ACS Applied Nano Materials . 4(2): 1314-1329. Nº de cites: 14

    [doi:10.1021/acsanm.0c02888]

  • Domenici G, Eduardo R, Castillo H, Orive G, Carcaboso AM and Brito C.

    PDX-Derived Ewing's Sarcoma Cells Retain High Viability and Disease Phenotype in Alginate Encapsulated Spheroid Cultures

    Cancers . 13(4): 879. Nº de cites: 7

    [doi:10.3390/cancers13040879]

  • Thomas L, Smith N, Saunders D, Zalles M, Gulej R, Lerner M, Fung KM, Carcaboso AM and Towner RA.

    OKlahoma Nitrone-007: novel treatment for diffuse intrinsic pontine glioma

    JOURNAL OF TRANSLATIONAL MEDICINE . 18(1): 424-424. Nº de cites: 11

    [doi:10.1186/s12967-020-02593-5]

  • Balakrishnan I, Danis E, Pierce A, Madhavan K, Wang D, Dahl N, Sanford B, Birks DK, Davidson N, Metselaar DS, Meel MH, Lemma R, Donson A, Vijmasi T, Katagi H, Sola I, Fosmire S, Alimova I, Steiner J, Gilani A, Hulleman E, Serkova NJ, Hashizume R, Hawkins C, Carcaboso AM, Gupta N, Monje M, Jabado N, Jones K, Foreman N, Green A, Vibhakar R and Venkataraman S.

    Senescence Induced by BMI1 Inhibition Is a Therapeutic Vulnerability in H3K27M-Mutant DIPG

    CELL REPORTS . 33(3): 108286-108286. Nº de cites: 41

    [doi:10.1016/j.celrep.2020.108286]

  • Martinez-Lage M, Torres-Ruiz R, Puig-Serra P, Moreno-Gaona P, Martin MC, Moya FJ, Quintana-Bustamante O, Garcia-Silva S, Carcaboso AM, Petazzi P, Bueno C, Mora J, Peinado H, Segovia JC, Menendez P and Rodriguez-Perales S.

    In vivo CRISPR/Cas9 targeting of fusion oncogenes for selective elimination of cancer cells

    NATURE COMMUNICATIONS . 11(1): 5060-5060. Nº de cites: 61

    [doi:10.1038/s41467-020-18875-x]

  • Sánchez-Molina S, Figuerola-Bou E, Blanco ME, Sanchez-Jimenez M, Táboas-Outón P, Gomez-Gonzalez S, Ballaré C, García-Domínguez DJ, Prada-Varela E, Hontecillas-Prieto L, Carcaboso AM, Tirado ÓM, Hernandez-Muñoz MI, de Álava E, Lavarino C, Di Croce L and Mora J.

    RING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesis

    Science Advances . 6(43): 3058. Nº de cites: 24

    [doi:10.1126/sciadv.aba3058]